Illumina, Inc.
ILMN · NASDAQ · USD · Healthcare
1What is happening
Illumina, Inc. has fallen 31% since its 6-week high on 06/10/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-31.1%
Other view · 20 analystsHorizon: 12 months10 Buy · 7 Hold · 4 Sell2Our assessment
Dip in progress53How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-31.1%
Highest daily price: $309.35 on 06/10/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-31.1%
Highest price in 52 weeks: $309.35 (Yahoo)
Why is it down?
quarterly numbers- ·From its 6-week high of $309.35 on 06/10/2026 the price fell 31.1% to $213.13.
- ·The biggest single-day drop was 18.6% on 30/10/2026.
- ·That was right after the quarterly numbers. Results were 6% above expectations, so the market reacted to the outlook or details, not the headline number.
- ·No clear news driver in the last 10 days.
- ·The whole market is down 5.6% from its 60-day high, so part of this is not about the company.
- ·Other Diagnostics & Research stocks we track are down only 5.2% on average, so this is mostly about the company. See all 77 in this sector →
Drops after numbers usually take a few weeks to settle. The score already accounts for the miss.
What analysts expect
20 analysts disagree. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 1048 %
- Hold
- 733 %
- Sell
- 419 %
Average price target$259.85
$165.00 to $365.00 · today $213.13
$165.00Ø $259.85$365.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
The company in figures
- Market value
- 32.2 bn $
- All shares together at the current price.
- P/E
- 36.7
- Price divided by earnings per share, last 12 months.
- 52-week range
- $112.65 – $309.35
- Lowest and highest price of the last year.
Catalysts
37 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 29/10/2026 +6.1% vs estimate
Key figures
- Market value
- 32.2 bn $Large cap
- P/E
- 36.7
- Volume today
- 0.7 × Øabout usual
- Beta
- 1.45swings more than the market
- 52-week range
- $112.65 – $309.35price at 51 % of the range
About Illumina, Inc.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
- Headquarters:
- San Diego, United States
- 52-week range:
- $112.65 – $309.35
- Website:
- illumina.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.